Bristol Myers Squibb Company Revenue per Employee (BMY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bristol myers Squibb Company  (NYSE: BMY)
 

Bristol Myers Squibb's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 6.93% in the third quarter 2026, year on year to cumulative value of $50,033 million, Bristol Myers Squibb's revenue per employee grew on a trailing twelve months basis to $ 1,539,477, this marks a new company high.
Within the Healthcare sector Employees of 52 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 604, from total ranking in previous quarter at 738. Bristol Myers Squibb has 32,500 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMY Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 6.93 % 5.74 % 2.57 % 1.3 % 2.77 %
Sales per Employee (TTM) $ 1,539,477 1,513,415 1,491,754 1,482,892 1,477,969
BMY's Total Ranking # 604 # 738 # 598 # 585 # 588
Seq. Revenue Change 0.74 % 12.92 % -8.1 % 2.29 % -0.38 %

BMY Company Profile >> Back to BMY Efficiency Comparisons >> Compare BMY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 35
Healthcare Sector # 53
Overall Market # 604

Revenue per Employee Statistics
High Average Low
$ 1,539,477 $ 848,833 $ 486,338
(Sep 30 2026)   (June 30. 2013)



Financial Statements
Bristol Myers Squibb's Revenue MRQ $ 13,069 Millions Visit BMY's Income Statement
Bristol Myers Squibb's Revenues TTM $ 50,033 Millions Visit BMY's aggregate revenue growth
What are BMY's Sales? Visit BMY's Sales by Segment




Other Ratios
Bristol Myers Squibb's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BMY's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BMY's Competitors
Revenue per Employee for BMY's Suppliers
Revenue per Employee for BMY's Customers

You may also want to know
BMY's Sales Growth Rates BMY's Pe Price to earnings ratio BMY's Receivables Turnover Ratio BMY's Stock Quote
BMY's Net Income Growth Rates BMY's Ps Price to Sales ratio BMY's Sales per Employee BMY's Asset Turnover Ratio
BMY's Net Margin BMY's Pb Price to Book ratio BMY's Financial Strength Ratios BMY's Dividend Payout Ratio
Date modified: 2026-10-30T16:58:13+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Sarepta Therapeutics Inc   2,342,920.96 $ 1,956.339  Million 835 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Madrigal Pharmaceuticals Inc   1,560,590.16 $ 1,427.940  Million 915 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Acadia Pharmaceuticals Inc   1,506,642.86 $ 1,202.301  Million 798 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Lantheus Holdings Inc   1,309,212.07 $ 1,561.890  Million 1,193 
Heron Therapeutics Inc   1,167,640.63 $ 149.458  Million 128 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Abbvie Inc   1,158,140.35 $ 66,014.000  Million 57,000 
Biomarin Pharmaceutical Inc  1,134,780.19 $ 3,655.127  Million 3,221 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.